Innovation is the Key to the Future of Medicine

Toby CosgroveCourtesy of The Cleveland ClinicBill Gates once said that if business in the 1980s was about quality and in the 1990s it was about reengineering, then in the 2000s it will be about velocity. The rate of change is brutal. Obsolescence doesn't creep anymore, it leaps. The situation is best expressed in the Latin phrase absolutum obsoletum: If it works, it's out of date. In terms of shelf life, any technology at the peak of its adoption curve has passed its expiration date. You need to

Written byToby Cosgrove
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Courtesy of The Cleveland Clinic

Bill Gates once said that if business in the 1980s was about quality and in the 1990s it was about reengineering, then in the 2000s it will be about velocity. The rate of change is brutal. Obsolescence doesn't creep anymore, it leaps. The situation is best expressed in the Latin phrase absolutum obsoletum: If it works, it's out of date. In terms of shelf life, any technology at the peak of its adoption curve has passed its expiration date. You need to foster innovation and continually relaunch proprietary technology, or prepare for diminishing returns.

What precisely does "innovation" mean in the context of health care? It's not just good ideas, as the world is full of ideas that go nowhere. An innovation is an idea that has been put to work. Having an idea doesn't make you an innovator any more than having a brush ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies